More frequent diagnosis of attention deficit–hyperactivity disorder

New England Journal of Medicine

Volumn 333, Issue 14, 1995, Pages 944-

  Swanson, James M ^a   Lerner, Marc ^a   Williams, Lillie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

DRUG MANUFACTURE; HUMAN; LETTER; MINIMAL BRAIN DYSFUNCTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; HUMAN; METHYLPHENIDATE; PREVALENCE; UNITED STATES;

EID: 0029097239     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199510053331419     Document Type: Letter

References (5)

1. Introduction. In: Shaywitz SE, Shaywitz BA, eds, Attention deficit disorder comes of age: toward the twenty-first century. Austin, Tex: Pro-Ed, 1992:1-9.
2. Wallis C. An epidemic of attention deficit disorder. Time. July 18, 1994;144:42-50.
3. Swanson JM, McBurnett K, Christian D, Wigal T Stimulant medications and the treatment of children with ADHD. Adv Clin Child Psychol 1995; 17: 265-322
4. Physician drug and diagnosis audit, 1990–1994. Newton, Mass.: Scott-Levin Associates, 1994.
5. International Narcotics Control Board. Report of the International Narcotics Control Board for 1994. Vienna, Austria: United Nations, 1994.